Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep versus non-deep neuromuscular blockade during cervical spine surgery
2014-005238-76Phase 4Completed
- Sponsor
- Centro Hospitalar do Porto
- Start
- Mar 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Sugammadex, rocuronium, propofol and remifentanil (2 arms), sponsored by Centro Hospitalar do Porto. Primary endpoint: BIS signal variability during maintenance anesthesia. Started Mar 2015; status: completed.
02
Drugs
Sugammadexrocuroniumpropofolremifentanil
Beyond the preview
Go deeper on 2014-005238-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005238-76.